Targeted next-generation sequencing identifies the disruption of the <i>SHANK3</i> and <i>RYR2</i> genes in a patient carrying a de novo t(1;22)(q43;q13.3) associated with signs of Phelan-McDermid syndrome. The gene discussed is RYR2; the disease is Phelan-McDermid syndrome.